SNDX icon

Syndax Pharmaceuticals
SNDX

Overview Fund Activity

189 hedge funds and large institutions have $2.15B invested in Syndax Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 54 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+12
Holders Change %
+6.78%
% of All Funds
2.74%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.14%
New
30
Increased
82
Reduced
54
Closed
18
Calls
$8.74M
Puts
$8.25M
Net Calls
+$484K
Net Calls Change
-$335K

Top Buyers

1
ITP
1
Iron Triangle Partners
Connecticut
$23.2M
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$17.5M
3
Bank of America
3
Bank of America
North Carolina
$39.4M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$117M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$12.8M

Top Sellers

1
APM
1
Avidity Partners Management
Texas
$57.4M
2
Morgan Stanley
2
Morgan Stanley
New York
$43.2M
3
CAM
3
Cormorant Asset Management
Massachusetts
$0
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$49.2M
5
Millennium Management
5
Millennium Management
New York
$16.2M
Name Holding Trade Value Shares
Change 		Shares
Change %
BCM
201
Bayesian Capital Management
New York
– -$327K -15,116 Closed
VF
202
Virtu Financial
New York
– -$258K -11,948 Closed
Capstone Investment Advisors
203
Capstone Investment Advisors
New York
– -$235K -10,895 Closed
GWS
204
Glassman Wealth Services
Virginia
– -$2.14K -99 Closed
Northwestern Mutual Wealth Management
205
Northwestern Mutual Wealth Management
Wisconsin
– -$1.08K -50 Closed
AssetMark Inc
206
AssetMark Inc
California
– -$216 -10 Closed
5 6 7 8
9